4basebio says "tier one" partner tests vaccine from its template
(Alliance News) - 4basebio PLC on Monday said its synthetic DNA product has been used in US clinical trials by a "global tier one" pharmaceutical partner. Read More
| Price | 575.00p on 22-01-2026 at 11:50:06 |
|---|---|
| Change | 0.00p 0% |
| Buy | 600.00p |
| Sell | 550.00p |
| Last Trade: | Sell 84.00 at 561.25p |
| Day's Volume: | 84 |
| Last Close: | 575.00p |
| Open: | 575.00p |
| ISIN: | GB00BMCLYF79 |
| Day's Range | 575.00p - 575.00p |
| 52wk Range: | 575.00p - 1,230.00p |
| Market Capitalisation: | £89.04m |
| VWAP: | 561.25p |
| Shares in Issue: | 15.48m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
4basebio Plc (4BB) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 84 | 561.25p | Ordinary |
09:58:39 - 22-Jan-26 |
| Buy* | 803 | 584.40p | Ordinary |
16:23:39 - 21-Jan-26 |
| Sell* | 1 | 560.00p | Ordinary |
16:16:48 - 21-Jan-26 |
| Buy* | 84 | 584.40p | Ordinary |
16:07:36 - 21-Jan-26 |
| Buy* | 1 | 584.40p | Ordinary |
15:41:48 - 21-Jan-26 |
| Sell* | 8 | 560.00p | Ordinary |
15:25:21 - 21-Jan-26 |
| Buy* | 250 | 600.00p | Ordinary |
08:22:30 - 21-Jan-26 |
| Buy* | 140 | 594.00p | Ordinary |
08:20:05 - 21-Jan-26 |
| Unknown* | 1,673 | 597.40p | Ordinary |
11:26:17 - 20-Jan-26 |
| Unknown* | 1,673 | 597.40p | Ordinary |
11:25:26 - 20-Jan-26 |
4basebio Plc (4BB) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 27th Oct 2025 7:00 am | PRN | Synthetic opDNA® utilised in Phase I/II US clinical trials |
| 10th Oct 2025 11:30 am | PRN | Result of Extraordinary General Meeting |
| 30th Sep 2025 4:20 pm | PRN | Director Dealing |
| 29th Sep 2025 7:00 am | PRN | Half-year Report |
| 22nd Jul 2025 7:00 am | PRN | Employee Long Term Incentive Plan and Issue of Equity |
| 8th Jul 2025 10:30 am | PRN | Director Appointment, Board Change |
| 3rd Jul 2025 7:00 am | PRN | Holding(s) in Company |
| 3rd Jul 2025 7:00 am | PRN | Holding(s) in Company |
| 2nd Jul 2025 7:00 am | PRN | Holding(s) in Company |
| 2nd Jul 2025 7:00 am | PRN | Holding(s) in Company |